Novo Nordisk and AWS bring agentic AI into drug discovery
AI News (TechForge)
Read full postNovo Nordisk is partnering with AWS to integrate AI agents into drug discovery, establishing a co-innovation hub in London to accelerate research from target identification to clinical dosing. The collaboration leverages AWS cloud and AI tools, including generative AI, to enhance workflows and reduce documentation time significantly.




